Back
Milestone Pharmaceuticals, Inc. Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison
Sell
41
MIST
Milestone Pharmaceuticals, Inc.
Last Price:
$2.15
Seasonality Move:
-24.75%
Buy
51
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$422.40
Seasonality Move:
1.76%
Sell
41
Milestone Pharmaceuticals, Inc. (MIST)
is a Sell
Is Milestone Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Milestone Pharmaceuticals, Inc. [MIST] share price is $2.05. The Score for MIST is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Buy
Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $406.40. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MIST Stock Price Chart
What is Milestone Pharmaceuticals, Inc.'s stock price today?
-
The Milestone Pharmaceuticals, Inc. share price today is $2.05The current trend is relatively stagnant and MIST is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals, Inc.'s stock price today?
-
The Alnylam Pharmaceuticals, Inc. share price today is $406.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
MIST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 43.19 | Sell |
| Chaikin Money Flow: | -716905 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.03 - 2.65) | Sell |
| Bollinger Bands (100): | (1.75 - 2.33) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -10.47 | Sell |
| Relative Strength Index (14 RSI): | 45.44 | Sell |
| Chaikin Money Flow: | 1250787 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (389.35 - 442.97) | Sell |
| Bollinger Bands (100): | (421.37 - 470.37) | Sell |
MIST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.02 | Buy |
| 20-day SMA: | 2.26 | Sell |
| 50-day SMA: | 2.19 | Sell |
| 200-day SMA: | 1.75 | Buy |
| 8-day EMA: | 2.06 | Sell |
| 20-day EMA: | 2.17 | Sell |
| 50-day EMA: | 2.05 | Buy |
| 200-day EMA: | 1.05 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 399.74 | Buy |
| 20-day SMA: | 404.73 | Buy |
| 50-day SMA: | 433.46 | Sell |
| 200-day SMA: | 372.66 | Buy |
| 8-day EMA: | 400.93 | Buy |
| 20-day EMA: | 408.61 | Sell |
| 50-day EMA: | 424.38 | Sell |
| 200-day EMA: | 384.26 | Buy |
Milestone Pharmaceuticals, Inc. Earnings Growth & MIST Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.31 per share.
Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.09 per share, and an increase next year of $6.72 per share.
Milestone Pharmaceuticals, Inc. Technical Analysis
| Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals, Inc. Technical Analysis
| Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||